Published Date：Jan. 2021
Industry：Pharma & Healthcare
Pages：100 Table Number：127
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Cannabis Drugs market in this environment. In terms of revenue, this research report indicated that the global Cannabis Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Cannabis Drugs industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Greenwich Biosciences aims at producing XX Cannabis Drugs in 2020, with XX % production to take place in global market, Abbive accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Cannabis Drugs Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Cannabis Drugs Market? Greenwich Biosciences Abbive Insys Therapeutics Bausch Health GW Pharmaceuticals Unimed Pharmaceuticals Indevus Pharmaceuticals Pharmos ... Major Type of Cannabis Drugs Covered in XYZResearch report: Oral Spray Capsule Tablets Application Segments Covered in XYZResearch Market Hospital Clinic Other For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Cannabis Drugs Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Oral Spray -Product Introduction and Major Manufacturers 1.1.2 Capsule -Product Introduction and Major Manufacturers 1.1.3 Tablets -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Cannabis Drugs Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Cannabis Drugs Market 3.1.1 Top Companies leading Cannabis Drugs Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Cannabis Drugs Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Cannabis Drugs Market 3.2.1 Top Companies leading Cannabis Drugs Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Cannabis Drugs Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Cannabis Drugs Market 3.3.1 Top Companies leading Cannabis Drugs Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Cannabis Drugs Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Cannabis Drugs Market 3.4.1 Top Companies leading Cannabis Drugs Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Cannabis Drugs Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Cannabis Drugs Market 3.5.1 Top Companies leading Cannabis Drugs Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Cannabis Drugs Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Cannabis Drugs Market 3.6.1 Top Companies leading Cannabis Drugs Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Cannabis Drugs Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Cannabis Drugs Market 3.7.1 Top Companies leading Cannabis Drugs Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Cannabis Drugs Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Cannabis Drugs Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Cannabis Drugs Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Cannabis Drugs Sales and Growth Rate (2021-2026) 5.2 Global Cannabis Drugs Sales Value and Growth Rate (2021-2026) 6 Cannabis Drugs Competitive Analysis 6.1 Greenwich Biosciences 6.1.1 Greenwich Biosciences Company Profiles 6.1.2 Greenwich Biosciences Product Introduction 6.1.3 Greenwich Biosciences Cannabis Drugs Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Abbive 6.2.1 Abbive Company Profiles 6.2.2 Abbive Product Introduction 6.2.3 Abbive Cannabis Drugs Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Insys Therapeutics 6.3.1 Insys Therapeutics Company Profiles 6.3.2 Insys Therapeutics Product Introduction 6.3.3 Insys Therapeutics Cannabis Drugs Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Bausch Health 6.4.1 Bausch Health Company Profiles 6.4.2 Bausch Health Product Introduction 6.4.3 Bausch Health Cannabis Drugs Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 GW Pharmaceuticals 6.5.1 GW Pharmaceuticals Company Profiles 6.5.2 GW Pharmaceuticals Product Introduction 6.5.3 GW Pharmaceuticals Cannabis Drugs Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Unimed Pharmaceuticals 6.6.1 Unimed Pharmaceuticals Company Profiles 6.6.2 Unimed Pharmaceuticals Product Introduction 6.6.3 Unimed Pharmaceuticals Cannabis Drugs Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Indevus Pharmaceuticals 6.7.1 Indevus Pharmaceuticals Company Profiles 6.7.2 Indevus Pharmaceuticals Product Introduction 6.7.3 Indevus Pharmaceuticals Cannabis Drugs Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 Pharmos 6.8.1 Pharmos Company Profiles 6.8.2 Pharmos Product Introduction 6.8.3 Pharmos Cannabis Drugs Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Cannabis Drugs Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Cannabis Drugs Sales (K Unit) by Type (2015-2026) Figure Global Cannabis Drugs Sales (K Unit) and Growth Rate (2015-2026) Figure Global Cannabis Drugs Sales Market Share (%) by Type (2019 -2020) Table Global Cannabis Drugs Sales Value (Million USD) by Type (2015-2026) Figure Global Cannabis Drugs Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Cannabis Drugs Sales Value Market Share (%) by Type (2019-2020) Table Global Cannabis Drugs Sales (K Unit) by Application (2015-2026) Table China Cannabis Drugs Sales (K Unit) of Major Company (2015-2020) Table China Cannabis Drugs Sales Market Share of Major Company (2015-2020) Table China Cannabis Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure China Cannabis Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table China Cannabis Drugs Sales Value Share of Major Company (2015-2020) Table China Cannabis Drugs Price (USD/Unit), by Type (2019-2020) Table China Cannabis Drugs Sales (Unit) by Type (2015-2026) Figure China Cannabis Drugs Sales (Unit) by Type (2015-2026) Table EU Cannabis Drugs Sales (K Unit) of Major Company (2015-2020) Table EU Cannabis Drugs Sales Market Share of Major Company (2015-2020) Table EU Cannabis Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure EU Cannabis Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Cannabis Drugs Sales Value Share of Major Company (2015-2020) Table EU Cannabis Drugs Price (USD/Unit), by Type (2019-2020) Table EU Cannabis Drugs Sales (Unit) by Type (2015-2026) Figure EU Cannabis Drugs Sales (Unit) by Type (2015-2026) Table USA Cannabis Drugs Sales (K Unit) of Major Company (2015-2020) Table USA Cannabis Drugs Sales Market Share of Major Company (2015-2020) Table USA Cannabis Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure USA Cannabis Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Cannabis Drugs Sales Value Share of Major Company (2015-2020) Table USA Cannabis Drugs Price (USD/Unit), by Type (2019-2020) Table USA Cannabis Drugs Sales (Unit) by Type (2015-2026) Figure USA Cannabis Drugs Sales (Unit) by Type (2015-2026) Table Japan Cannabis Drugs Sales (K Unit) of Major Company (2015-2020) Table Japan Cannabis Drugs Sales Market Share of Major Company (2015-2020) Table Japan Cannabis Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Cannabis Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Cannabis Drugs Sales Value Share of Major Company (2015-2020) Table Japan Cannabis Drugs Price (USD/Unit), by Type (2019-2020) Table Japan Cannabis Drugs Sales (Unit) by Type (2015-2026) Figure Japan Cannabis Drugs Sales (Unit) by Type (2015-2026) Table India Cannabis Drugs Sales (K Unit) of Major Company (2015-2020) Table India Cannabis Drugs Sales Market Share of Major Company (2015-2020) Table India Cannabis Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure India Cannabis Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table India Cannabis Drugs Sales Value Share of Major Company (2015-2020) Table India Cannabis Drugs Price (USD/Unit), by Type (2019-2020) Table India Cannabis Drugs Sales (Unit) by Type (2015-2026) Figure India Cannabis Drugs Sales (Unit) by Type (2015-2026) Table Southeast Asia Cannabis Drugs Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Cannabis Drugs Sales Market Share of Major Company (2015-2020) Table Southeast Asia Cannabis Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Cannabis Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Cannabis Drugs Sales Value Share of Major Company (2015-2020) Table Southeast Asia Cannabis Drugs Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Cannabis Drugs Sales (Unit) by Type (2015-2026) Figure Southeast Asia Cannabis Drugs Sales (Unit) by Type (2015-2026) Table South America Cannabis Drugs Sales (K Unit) of Major Company (2015-2020) Table South America Cannabis Drugs Sales Market Share of Major Company (2015-2020) Table South America Cannabis Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure South America Cannabis Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Cannabis Drugs Sales Value Share of Major Company (2015-2020) Table South America Cannabis Drugs Price (USD/Unit), by Type (2019-2020) Table South America Cannabis Drugs Sales (Unit) by Type (2015-2026) Figure South America Cannabis Drugs Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Cannabis Drugs Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Cannabis Drugs Figure Cost Structure of Cannabis Drugs in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Cannabis Drugs Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Cannabis Drugs Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table Greenwich Biosciences Profiles Table Greenwich Biosciences Cannabis Drugs Product Introduction Table Greenwich Biosciences Cannabis Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Greenwich Biosciences SWOT Analysis Table Abbive Profiles Table Abbive Cannabis Drugs Product Introduction Table Abbive Cannabis Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Abbive SWOT Analysis Table Insys Therapeutics Profiles Table Insys Therapeutics Cannabis Drugs Product Introduction Table Insys Therapeutics Cannabis Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Insys Therapeutics SWOT Analysis Table Bausch Health Profiles Table Bausch Health Cannabis Drugs Product Introduction Table Bausch Health Cannabis Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Bausch Health SWOT Analysis Table GW Pharmaceuticals Profiles Table GW Pharmaceuticals Cannabis Drugs Product Introduction Table GW Pharmaceuticals Cannabis Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure GW Pharmaceuticals SWOT Analysis Table Unimed Pharmaceuticals Profiles Table Unimed Pharmaceuticals Cannabis Drugs Product Introduction Table Unimed Pharmaceuticals Cannabis Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Unimed Pharmaceuticals SWOT Analysis Table Indevus Pharmaceuticals Profiles Table Indevus Pharmaceuticals Cannabis Drugs Product Introduction Table Indevus Pharmaceuticals Cannabis Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Indevus Pharmaceuticals SWOT Analysis Table Pharmos Profiles Table Pharmos Cannabis Drugs Product Introduction Table Pharmos Cannabis Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
